Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

School of Pharmacy : Yosselson-Superstine Shimona

Researchers

 Last updated June 2021 - School of Pharmacy

List of Publications

(1) Eliasaf A, Amitai A, Maram Edry M, Yosselson Superstine S, Rotman Pikielny P. Compliance, Persistence, and Preferences Regarding Osteoporosis Treatment During Active Therapy or Drug Holiday. J Clin Pharmacol 2016:1416-1422.

(2) Yosselson-Superstine S. Drug utilization: National and international comparisons. Isr J Med Sci 1992;28(8-9):728-730.

(3) Slater PE, Aviram H, Dagan M, Yosselson-Superstine S, Cristal R, Rubinstein I, et al. Breast cancer screening in Tel Aviv. Eur J Epidemiol 1990;6(3):253-256.

(4) Yosselson-Superstine S. Drug interferences in therapeutic drug monitoring. G ITAL CHIM CLIN 1989;14(1):23-34.

(5) Yosselson-Superstine S, Sinai Y. Drug Interference with Urine Protein Determination. Clin Chem Lab Med 1986;24(1):103-106.

(6) Yosselson‐Superstine S, Gutman R, Magora F. THE PROPRIETY OF NARCOTIC USAGE IN HOSPITALIZED PATIENTS. J Clin Pharm Ther 1986;11(1):55-60.

(7) Touitou E, Yosselson‐Superstine S. THEOPHYLLINE VERSUS AMINOPHYLLINE IN RECTAL ADMINISTRATION. J Clin Pharm Ther 1985;10(2):211-217.

(8) Yosselson-Superstine S, Lipman AG, Sanders SH. Adjunctive antianxiety agents in the management of chronic pain. Isr J Med Sci 1985;21(2):113-117.

(9) Yosselson-Superstine S. Drug interference with pregnancy tests. Am J Hosp Pharm 1984;41(6):1098.

(10) Yosselson-Superstine S. Drug Interferences with Plasma Assays in Therapeutic Drug Monitoring. Clin Pharmacokinet 1984;9(1):67-87.

(11) Zbaida S, Silman‐Greenspan J, Yosselson‐Superstine S, Merin E. In vitro studies on the metabolism of cimetidine by rat liver microsomes—identification of a new N‐desmethylcimetidine metabolite. Biopharm Drug Dispos 1984;5(4):415-419.

(12) Yosselson-Superstine S. Drug interference with clinical tests performed by a 20-channel computerized autoanalyzer. Am J Hosp Pharm 1982;39(5):848-849.

(13) Yosselson-Superstine S, Lipman AG. Chlordiazepoxide interaction with levodopa. Ann Intern Med 1982;96(2):259-260.

(14) Yosselson‐Superstine S, Weiss T. DRUG‐RELATED HOSPITALIZATION IN PAEDIATRIC PATIENTS. J Clin Pharm Ther 1982;7(3):195-203.

(15) Yosselson-Superstine S, Yanuka Y, Iskai S. Relationship between quinidine concentrations measured in saliva and erythrocytes, and in serum. Int J Clin Pharmacol Ther Toxicol 1982;20(4):181-186.

(16) Yosselson-Superstine S, Merin E. A methodology for display of antimicrobial utilization data in ambulatory patients. Hosp Formul 1981;16(12):1468-"1470, 1475".

(17) Yanuka Y, Yosselson‐Superstine S, Geryes A, Superstine E. Assignment of conformation and configuration to potassium permanganate oxidation products of quinidine. J Pharm Sci 1981;70(6):675-679.

(18) Yanuka Y, Yosselson‐Superstine S, Geryes A, Superstine E. Impact of stable conformation of cinchona alkaloids on protonation site. J Pharm Sci 1981;70(6):679-682.

(19) Yosselson-Superstine S, Granit D, Superstine E. Theophylline interference with the phosphotungstate uric acid test. Am J Hosp Pharm 1980;37(11):1522-1524.

(20) Yosselson-Superstine S, Granit D, Superstine E. Drug interferences with tests performed by a 12-channel autoanalyzer. Am J Hosp Pharm 1980;37(10):1333-1338.

(21) Yosselson-Superstine S, Granit D, Superstine E. Drug interference with the phosphotungstate uric acid test. Am J Hosp Pharm 1980;37(11).

(22) Yosselson‐Superstine S, Sternik D, Liebenzon D. Prescribing patterns in psychiatric hospitals in Israel. Acta Psychiatr Scand 1979;60(5):477-482.